These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16260447)

  • 1. Responses to cardiovascular drugs during alcohol withdrawal.
    Kähkönen S
    Alcohol Alcohol; 2006; 41(1):11-3. PubMed ID: 16260447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal.
    Kähkönen S; Bondarenko B; Lipsanen J; Zvartau E
    Int J Psychophysiol; 2007 Dec; 66(3):225-30. PubMed ID: 17761330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of verapamil, an antagonist of L-type calcium channels, on cardiovascular symptoms in alcohol withdrawal.
    Kähkönen S; Bondarenko BB; Lipsanen J; Zvartau EE
    Neuropsychobiology; 2008; 58(3-4):123-7. PubMed ID: 18997479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-type Ca2+ channels mediate cardiovascular symptoms of alcohol withdrawal in humans.
    Kähkönen S; Bondarenko BB
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):45-8. PubMed ID: 14687856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol withdrawal changes cardiovascular responses to propranolol challenge.
    Kähkönen S
    Neuropsychobiology; 2003; 47(4):192-7. PubMed ID: 12824742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative influence of propranolol and verapamil on glycemic control and histamine sensitivity associated with L-thyroxine-induced hyperthyroidism - an experimental study.
    Bhatt PA; Makwana D
    Fundam Clin Pharmacol; 2008 Feb; 22(1):53-9. PubMed ID: 18251722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil.
    Shulman A; Jagoda J; Laycock G; Kelly H
    Aust Fam Physician; 1998 Jan; 27 Suppl 1():S19-24. PubMed ID: 9503731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.
    Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL
    J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered cardiovascular responses to nitrosorbide in alcohol withdrawal.
    Kähkönen S; Zvartau EE
    Neuropsychobiology; 2003; 48(3):124-30. PubMed ID: 14586161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate variability and sympathetic skin response in male patients suffering from acute alcohol withdrawal syndrome.
    Bär KJ; Boettger MK; Neubauer R; Grotelüschen M; Jochum T; Baier V; Sauer H; Voss A
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1592-8. PubMed ID: 16930222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide mediates cardiovascular symptoms in alcohol withdrawal.
    Kähkönen S; Boris B; Edwin Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):761-5. PubMed ID: 17291656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue perfusion in relation to cardiac output during continuous positive-pressure ventilation and administration of propranolol or verapamil.
    Elowsson P; Norlén K; Jakobson S
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):816-24. PubMed ID: 9698959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly.
    Groszmann RJ
    Gastroenterology; 1997 Nov; 113(5):1794-7. PubMed ID: 9352888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tolerance to nitrates in patients with angina and effect of plasmapheresis].
    Koziolova NA
    Ter Arkh; 2001; 73(12):21-5. PubMed ID: 11858102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
    Rogers R; Prpic R
    Med J Aust; 1998 Oct; 169(8):425-7. PubMed ID: 9830391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
    Krämer B; Kübler W
    Dtsch Med Wochenschr; 1984 Mar; 109(12):465-71. PubMed ID: 6142815
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs in secondary prevention of ischemic heart disease: achievements, problems and prospects].
    Metelitsa VI
    Kardiologiia; 1989 Nov; 29(11):57-62. PubMed ID: 2575683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers in alcohol withdrawal.
    Neff DA; McQueen KD
    DICP; 1991 Jan; 25(1):31-2. PubMed ID: 1672570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.